Anemia in critically ill patients

Area of Science:

• Critical Care Medicine
• Hematology
• Pathophysiology

Background:

• Anemia is highly prevalent in acutely ill patients.
• It shares characteristics with anemia of chronic disease, including low serum iron, high ferritin, and low-to-normal transferrin levels.
• Inflammation plays a key role, affecting erythropoietin responsiveness and iron availability.

Purpose of the Study:

• To explore the mechanisms of anemia in critically ill patients.
• To evaluate management strategies including transfusion thresholds and recombinant human erythropoietin (rh-EPO).

Main Methods:

• Analysis of patient data regarding anemia markers (serum iron, ferritin, transferrin).
• Review of the role of inflammation and cytokines in anemia pathogenesis.
• Assessment of transfusion policies and the efficacy of rh-EPO.

Main Results:

• Inflammation blunts erythropoietin response and causes functional iron deficiency by trapping iron in phagocytic cells.
• Bone marrow remains capable of iron incorporation and response to rh-EPO.
• A restrictive transfusion policy (hemoglobin 7.0–9.0 g/dL) is effective, potentially superior to liberal regimens.
• rh-EPO can reduce red blood cell transfusion needs.

Conclusions:

• Anemia in critically ill patients is multifactorial, with inflammation as a central mechanism.
• Restrictive transfusion strategies are effective, with individualized higher thresholds for specific patient groups.
• rh-EPO is a viable alternative for managing anemia, though cost-benefit and optimal dosing require further study.